Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease: a Multicentre,Randomised, Double-blind, Placebo-controlled, Clinical Trial (MODIFI-IBD Trial)

NCT07582458 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Chronic Fatigue

Interventions

DRUG: Modafinil
DRUG: Placebo

Sponsor

Radboud University Medical Center